Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 1/2 1

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Advanced Solid Tumors 432Advanced Solid Tumor 352Solid Tumor 305Solid Tumors 246Mesothelioma 115Solid Tumor, Adult 76Mesothelioma, Malignant 72Carcinoma, Non-Small-Cell Lung 66Ovarian Neoplasms 47Melanoma 42Carcinoma, Renal Cell 37Colorectal Neoplasms 34Advanced or Metastatic Solid Tumors 32Uterine Cervical Neoplasms 31Stomach Neoplasms 31Solid Tumours 31Esophageal Neoplasms 30Neoplasms 27Pancreatic Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Breast Neoplasms 25Advanced Malignant Solid Tumors 25Triple Negative Breast Neoplasms 24Lung Neoplasms 24Small Cell Lung Carcinoma 23Advanced Solid Tumours 23Sarcoma 21Neoplasm Metastasis 21Advanced Malignant Solid Tumor 21Locally Advanced or Metastatic Solid Tumors 20

Interventions

atezolizumab 1NVP-BKM120 1Injections 1E7046 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Locally Advanced Solid Tumor × Other solid neoplasm × Clear all
NCT04975958 2025-06-22

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

Adlai Nortye Biopharma Co., Ltd.

Phase 1 Completed
47 enrolled
Other solid neoplasm

Locally Advanced Solid Tumor

NCT04084366 2025-03-26

Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

OBI Pharma, Inc

Phase 1/2 Terminated
44 enrolled 15 charts
Other solid neoplasm

Locally Advanced Solid Tumor

NCT06658353 2025-03-20

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

Jiangsu vcare pharmaceutical technology co., LTD

Phase 3 Recruiting
54 enrolled
Other solid neoplasm

Locally Advanced Solid Tumor

NCT06349408 2025-01-27

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Recruiting
250 enrolled
Other solid neoplasm

Locally Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡